IHC staining showed that the expression of E-cadherin and TRIM33 was enhanced while the levels of N-cadherin and Ki67 decreased in the control group (Fig. 6E), indicating that YOD1 inhibited EMT and the proliferation of HNSCC cells. Here, MKI67 is linked to head and neck squamous cell carcinoma.